OpenAI released GeneBench-Pro, a research-level benchmark for testing whether AI agents can reason through ambiguous computational-biology and translational-medicine problems rather than simply answer clean exam-style questions. The benchmark includes 129 expert-created questions across genomics, quantitative biology, pharmacogenomics, and clinical/translational domains; OpenAI reports GPT5.6 Sol reaching 28.7% overall pass rate and 31.5% in Pro mode, while GPT5 scored below 5%.
OpenAI released GeneBench-Pro, a research-level benchmark for testing whether AI agents can reason through ambiguous computational-biology and translational-medicine problems rather than simply answer clean exam-style questions.
The key signal is rapid movement toward frontier models that can help with high-value biological reasoning, while OpenAI itself notes that current models still solve fewer than one-third of these expert tasks and are not reliable replacements for human specialists.
Read the evidence behind this analysis. External links open in a new tab.
OpenAI
A review of evidence across cognitive science, education, medicine, and human-factors research finds that fully offloading mental work to AI can weaken the acquisition and retention of the specific skills people stop practicing. The authors distinguish that evidence from broader claims about declining intelligence: effects on foundational abilities such as attention and working memory remain uncertain, while AI used as a collaborator, tutor, or source of feedback can preserve or improve learning.
In a randomized field experiment across a chain of middle and high schools in Turkey, giving teachers a generative-AI support tool reduced students’ intrinsic motivation by 0.11 standard deviations. Average academic performance did not change, but students taught by lower-performing teachers experienced significant declines in both performance and confidence, showing that a tool that makes lesson preparation easier for teachers does not automatically improve the student experience.
The NUS/Harbin-led team identifies a domain-specific form of generative-AI hallucination: molecular candidates can receive strong predicted binding scores while violating basic chemistry or producing physically impossible atomic arrangements. Its DrugRPG framework incorporates chemical-foundation-model priors and differentiable physical constraints during molecule generation, reducing severe steric clashes by 65.4% relative to the reported state-of-the-art baseline and increasing by 28.6% the share of generated candidates meeting combined potency, stability, and synthetic-feasibility criteria.